Schizophrenia in Thailand: Prevalence and burden of disease

Population Health Metrics

Volumn 8, Issue , 2010, Pages

  Phanthunane, Pudtan ^a,b   Vos, Theo ^a,b   Whiteford, Harvey ^b,c   Bertram, Melanie ^a,b   Udomratn, Pichet ^d  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Queensland Centre for Mental Health Research   (Australia)

^d PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

COST-BENEFIT ANALYSIS; DISABILITY; DISEASE PREVALENCE; EPIDEMIOLOGY; HEALTH SURVEY; HOSPITAL SECTOR; MENTAL HEALTH; META-ANALYSIS; MONTE CARLO ANALYSIS; MORTALITY RISK; POPULATION DISTRIBUTION; SOFTWARE; UNCERTAINTY ANALYSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; COMMUNITY MENTAL HEALTH; COMPUTER PROGRAM; DISABILITY; FEMALE; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; MONTE CARLO METHOD; MORTALITY; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REMISSION; SCHIZOPHRENIA; SEX RATIO; THAILAND;

THAILAND;

EID: 77955535171     PISSN: None     EISSN: 14787954     Source Type: Journal    
DOI: 10.1186/1478-7954-8-24     Document Type: Article

References (38)

1. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Medicine 2005, 2:413-433.
2. Responding to the burden of mental illness. , http://www.whoindia.org/LinkFiles/Commision_on_Macroeconomic_and_Health_01_12.pdf
3. Mathers CD, Lopez AD, Murray CJL. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001. Global Burden of Disease and Risk Factors 2006, 45-93. New York: Oxford University Press, Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL.
4. Bundhamcharoen K, Teerawatananon Y, Vos T, Begg S. Burden of disease and injuries in Thailand: priority setting for policy 2002, Nonthaburi: Ministry of Public Health.
5. Barbato A. Schizophrenia and public health 1998, Geneva: World Health Organization.
6. Lang HC, Su TP. The cost of schizophrenia treatment in Taiwan. Psychiatr Serv 2004, 55:928-930. 10.1176/appi.ps.55.8.928, 15292543.
7. Saha S, Barendregt JJ, Vos T, Whiteford H, McGrath J. Modelling disease frequency measures in schizophrenia epidemiology. Schizophr Res 2008, 104:246-254. 10.1016/j.schres.2008.05.022, 18602251.
8. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality. Epidemiol Rev 2008, 30:67-76. 10.1093/epirev/mxn001, 18480098.
9. Siriwanarangsun P, Kongsuk T, Arunpongpaisan S, Kittirattanapaiboon P, Charatsingha A. Prevalence of mental disorders in Thailand: a national survey 2003. J Ment Health Thai 2004, 12:177-178.
10. Barendregt J, van Oortmarssen G, Vos T, Murray C. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr 2003, 1:1-4. 10.1186/1478-7954-1-4, 156894, 12780936.
11. Reidpath DD, Allotey PA, Kouame A, Cummins RA. Measuring health in a vacuum: examining the disability weight of the DALY. Health Policy Plan 2003, 18:351-356. 10.1093/heapol/czg043, 14654511.
12. Siriwanarangsun P, . (Ed) The 2003 national epidemiology survey on mental health in Thailand 2003, Nonthaburi: Department of Mental Health, (Ed).
13. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The alcohol use disorders identification test, guideline for use in primary care 2001, Geneva: World Health Organization, 2.
14. The Mini-International Neuropsychiatry Interview (M.I.N.I.). , https://www.medical-outcomes.com/index.php
15. Udomratn P, Kittirattanapaiboon P, . (Eds) MINI Thai version 2003, Bangkok: Graffic Hut, 2, (Eds).
16. Perala J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsa E, Pirkola S, Partonen T, Tuulio-Henriksson A, Hintikka J, Kieseppa T, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007, 64:19-28. 10.1001/archpsyc.64.1.19, 17199051.
17. Ayuso-Mateos JL, Gutierrez-Recacha P, Haro JM, Chisholm D. Estimating the prevalence of schizophrenia in Spain using a disease model. Schizophr Res 2006, 86:194. 10.1016/j.schres.2006.06.003, 16859895.
18. Kruijshaar M, Barendregt J, van de Poll-Franse L. Estimating the prevalence of breast cancer using a disease model: data problems and trends. Popul Health Metr 2003, 1:5. 10.1186/1478-7954-1-5, 156644, 12773211.
19. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsen over time?. Arch Gen Psychiatry 2007, 64:1123-1131. 10.1001/archpsyc.64.10.1123, 17909124.
20. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997, 171:502-508. 10.1192/bjp.171.6.502, 9519087.
21. Osby U, Correia N, Brandt L, Ekbom A, Sparén P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000, 45:21. 10.1016/S0920-9964(99)00191-7, 10978869.
22. Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 1996, Cambridge: Harvard University Press.
23. Murray CJL, Salomon JA, Mathers CD, Alan D L, . (Eds) Summary Measures of Population Health: concepts, ethics, measurement and applications 2002, Geneva: World Health Organization, (Eds).
24. Phanthunane P, Chaipornsupaisan W, Vos T. A survey of severity, quality of life and current treatment patterns in people with schizophrenia in Thailand 2008 2008, Bangkok: SPICE project.
25. Stouthard ME, Essink-Bot M-L, Bonsel GJ, Barendregt JJ, Kramer PGN, van de Water HPA. Disability weights for diseases in the Netherland 1997, Rotterdam: Department of Public Health, Erasmus University Rotterdam.
26. Dingemans PMAJ, Linszen DH, Lenior ME, Smeets RMW. Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E). Psychopharmacology 1995, 122:263-267. 10.1007/BF02246547, 8748395.
27. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia 1999, Canberra: Australian Institute of Health and Welfare.
28. Haby MM, Carter R, Mihalopoulos C, Magnus A, Sanderson K, Andrews G, Vos T. Assessing cost-effectiveness - mental health: introduction to the study and methods. Aust N Z J Psychiatry 2004, 38:569-578.
29. Magnus A, Carr V, Mihalopoulos C, Carter R, Vos T. Assessing cost-effectiveness of drug interventions for schizophrenia. Aust N Z J Psychiatry 2005, 39:44-54.
30. The Thai working group on the Burden of Disease and Injuries Burden of disease and injuries in Thailand 2002, Bangkok: Ministry of Public Health, The Thai working group on the Burden of Disease and Injuries.
31. Joukamaa M, Heliovaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Mental disorders and cause-specific mortality. Br J Psychiatry 2001, 179:498-502. 10.1192/bjp.179.6.498, 11731351.
32. Victorian Burden of Disease study: Mortality and Morbidity in 2001. , http://www.health.vic.gov.au
33. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global burden of disease and risk factors 2006, New York: The World Bank and Oxford University Press.
34. Eaton WW, Martins SS, Nestadt G, Bienvenu OJ, Clarke D, Alexandre P. The burden of mental disorders. Epidemiol Rev 2008, 30:1-14. 10.1093/epirev/mxn011, 2683377, 18806255.
35. Messias EL, Chen C-Y, Eaton WW. Epidemiology of schizophrenia: review of findings and myths. Psychiatr Clin North Am 2007, 30:323-338. 10.1016/j.psc.2007.04.007, 2727721, 17720026.
36. Disease and injury regional estimates for 2004 [Internet]. , http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html
37. Global Burden of Disease (GBD). , http://www.who.int/healthinfo/global_burden_disease/en/
38. Average length of inpatient stay at psychiatric hospitals in Thailand from 2003 to 2009. , http://www.dmh.go.th/report/patient/avrgday.asp